Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01755975 · FLOW

Participant flow

Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma · Source last updated 2024-11-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Romidepsin 8 mg/m\^2/Lenalidomide 10 mg
    id
    FG000
    title
    Dose Level -1
  2. description
    Romidepsin 8 mg/m\^2/Lenalidomide 15 mg
    id
    FG001
    title
    Dose Level 1
  3. description
    Romidepsin 8 mg/m\^2/Lenalidomide 25 mg
    id
    FG002
    title
    Dose Level 2
  4. description
    Romidepsin 10 mg/m\^2/Lenalidomide 25 mg
    id
    FG003
    title
    Dose Level 3
  5. description
    Romidepsin 14 mg/m\^2/Lenalidomide 25 mg
    id
    FG004
    title
    Dose Level 4
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        2
      type
      Adverse Event
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        3
      3. group Id
        FG002
        num Subjects
        7
      4. group Id
        FG003
        num Subjects
        3
      5. group Id
        FG004
        num Subjects
        36
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        3
      3. group Id
        FG002
        num Subjects
        6
      4. group Id
        FG003
        num Subjects
        3
      5. group Id
        FG004
        num Subjects
        34
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        2
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Romidepsin 8 mg/m\^2/Lenalidomide 10 mg
    id
    FG000
    title
    Dose Level -1
  2. description
    Romidepsin 8 mg/m\^2/Lenalidomide 15 mg
    id
    FG001
    title
    Dose Level 1
  3. description
    Romidepsin 8 mg/m\^2/Lenalidomide 25 mg
    id
    FG002
    title
    Dose Level 2
  4. description
    Romidepsin 10 mg/m\^2/Lenalidomide 25 mg
    id
    FG003
    title
    Dose Level 3
  5. description
    Romidepsin 14 mg/m\^2/Lenalidomide 25 mg
    id
    FG004
    title
    Dose Level 4
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        2
      type
      Adverse Event
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        3
      3. group Id
        FG002
        num Subjects
        7
      4. group Id
        FG003
        num Subjects
        3
      5. group Id
        FG004
        num Subjects
        36
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        3
      3. group Id
        FG002
        num Subjects
        6
      4. group Id
        FG003
        num Subjects
        3
      5. group Id
        FG004
        num Subjects
        34
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        2
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice